Purchase Order 75F40122P00317
Award Date 8/3/22
Potential Completion Date 9/30/22
Potential Value $35K
Federal Agency
Ultimate Awardee
Not listed NAICS Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Competed under SAP
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Madison, WI 53711, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This federal contract award was issued by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), to Promega Corporation, a global life sciences company based in Madison, Wisconsin. The award, valued at $19,874.40, is for the procurement of 26 units of the LUCIFERASE 1000 REAGENT, Catalog # E4550, at $382.20 per unit. This is a Firm Fixed Price Blanket Purchase Agreement (BPA) call order with a completion date of March 8, 2012....
- This federal contract award to Promega Corporation, doing business as Promega Corp, is a Blanket Purchase Agreement (BPA) call with the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health (NIH). The $49,686 contract is for the procurement of 65 units of the Luciferase 1000 Reagent, Cat# E4550, at $382.20 per unit. This contract does not utilize a small business set-aside. Promega is a large, for-profit manufacturer of life sciences...
- This federal contract award to Promega Corporation, doing business as Promega Corp, was issued by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health (NIH). The $6,249.10 firm fixed-price purchase order is for the delivery of Promega's BRIGHT-GLO Luciferase Assay System, a specialized product used in biological research and molecular diagnostics. The award does not utilize a set-aside designation, reflecting Promega's position as...
- This is a $13,289.40 firm fixed price purchase order contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), to Promega Corporation for the purchase of luciferase reagents. The contract has an ultimate completion date of April 11, 2014 and does not utilize any set-aside designations. Promega Corporation is a global life sciences company that provides a wide range of products and services to support biomedical...
- This federal contract award is for the PROMEGA CORPORATION (doing business as Promega Corp) to provide the LUCIFERASE 1000 REAGENT to the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health (NIH). The contract has a Firm Fixed Price of $90,000.00 and an ultimate completion date of November 6, 2015. The contract did not utilize a set-aside designation. As a leading life sciences company, Promega has a significant presence in the...
- This federal contract award was made by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), to Promega Corporation, a global life sciences company. The contract is for the procurement of 26 units of the LUCIFERASE 1000 REAGENT, Catalog # E4550, at a firm fixed price of $375.01 per unit, for a total ceiling value of $19,500.52. The award date was November 3, 2011, and the ultimate completion date was February 29, 2012. This...
- This federal contract award is for the procurement of 26 units of Luciferase 1000 Reagent, Cat# E4550, by the National Institute of Allergy and Infectious Diseases (NIAID) from the prime contractor Promega Corporation, doing business as Promega Corp. The $19,500.52 Firm Fixed Price BPA Call contract does not utilize a set-aside designation. Promega is a global life sciences company that develops, manufactures, and markets products and services to support biomedical research and testing...
- This is a firm-fixed-price contract award by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), to Promega Corporation, a global life sciences company based in Madison, Wisconsin. The contract is for the purchase of the BRIGHT-GLO Luciferase Assay System, a product used in biological research and molecular diagnostics. The award ceiling value is $6,579.00. This is a Blanket Purchase Agreement (BPA) call, which is a type of...
- This is a $17,981.60 firm fixed price Blanket Purchase Agreement (BPA) call order awarded by the National Institute of Allergy and Infectious Diseases (NIAID) to Promega Corporation, a global manufacturer of life science research products, for a 10-pack of Luciferase Assay System kits. The order was placed under a larger $11.5 million BPA Promega holds with the Defense Health Agency for DNA analysis systems, forensic reagents, and related laboratory products. This contract does not utilize any...
- This is a $23,119.20 firm fixed price Blanket Purchase Agreement (BPA) call by the National Institute of Allergy and Infectious Diseases (NIAID) under the National Institutes of Health (NIH) to Promega Corporation, a global life sciences company, for the procurement of 45 units of the Luciferase Assay System 10-pack. The contract has no set-aside designation. Promega is the prime contractor and there are no major subcontractors mentioned. The Luciferase Assay System is a specialized laboratory...